Patient info Open main menu

Imodium Dual Action Relief tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No prescription needed Details

Medicine strength:
2 mg + 125 mg
Contains active substances:

Patient leaflet - Imodium Dual Action Relief tablets

1 What the medicine is for

The tablets are used to treat a short-lived attack of diarrhoea when it occurs with stomach cramps, bloating and wind.

The tablets contain loperamide hydrochloride, which helps reduce diarrhoea by slowing down an overactive bowel. It also helps the body to absorb more water and salts from the bowel. The tablets also contain simeticone, which breaks up the trapped wind in the bowel that causes cramps and bloating. This medicine is for use in adults and children aged 12 years and over.

2 Before taking this medicine

This medicine is suitable for most adults and children aged 12 years and over, but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist.

Do not take this medicine…

  • In children less than 12 years old.
  • If you are allergic (hypersensitive) to loperamide hydrochloride, simeticone or any of the other ingredients of the tablets (see section 6).
  • If you have a high temperature (e.g. above 38° C) or blood in your stools.
  • If you are having a flare up of an inflammatory bowel condition like ulcerative colitis.
  • If you have severe diarrhoea after taking antibiotics.
  • If you are constipated or your stomach appears swollen. If any of these apply to you, get advice from a doctor or pharmacist without taking IMODIUM® Dual Action Relief Tablets.

Project Name / Design

Product / Eurocode / Mat. ID Code

LITHO OFFSET

661 C

LITHO OFFSET

EMEA/Imodium Dual Action Tabs/12/UK/CCDS & Address Chg/CRD 16054/Leaflet/360341E/CDB

360341E

360341D 2995007

REPRESENTATION:

INSTRUCTION

Colours represented with a diagonal line have been modified to aid PDF approval.

PC Spec

Languages

PC-0002778

Job / Version No. Date

404475154_r4 English

18-08-2026

Val-de-Reuil
KVINT_00166_V2Date07-05-2025

Braille Grid

Profile Text Limit Bleed Fold/Technical

Stamping Area Perforation

Coding (Silent Zone) Seal Area

FONTS USED

HelveticaNeueLTStd-Cn HelveticaWorld-Bold HelveticaWorld-Regular OmnesRegular-Italic OmnesSemiBold-Italic OmnesSemibold-Roman ZapfDingbatsStd

Interstate-LightCondensed

19.65 pt
  • 2 –

    • Consult with a doctor if you have a history of drug abuse.
    • Loperamide is a type of opioid that acts directly on the gut when used as recommended but can cause other opioid effects when misused at high doses. Addiction is observed with opioids as a class.
    • Abuse and misuse of loperamide, one of the active ingredients in IMODIUM® Dual Action Relief Tablets, have been reported. Do not take this product for anything other than its intended use (see section 1) and never take more than the recommended amount (see section 3).
    • Serious heart problems (symptoms of which include fast or irregular heartbeat) have been reported in patients who have taken too much loperamide, one of the active ingredients in IMODIUM® Dual Action Relief Tablets.
    • In acute diarrhoea, the symptoms usually disappear within two days. If symptoms persist after this period, stop taking this medicine and contact your doctor.

Important information about some of the ingredients of IMODIUM® Dual Action Relief Tablets:

  • Each IMODIUM® Dual Action Relief Tablet contain less than 0.026 mg of benzyl alcohol. Benzyl alcohol may cause allergic reactions. Ask your doctor or pharmacist for advice if you have a liver or kidney disease, or if you are pregnant or breast-feeding. This is because large amounts of benzyl alcohol can build-up in your body and may cause side-effects (called “metabolic acidosis”).
  • This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
  • This medicine contains less than 0.00044 mg of alcohol (ethanol) in each tablet. The small amount of alcohol in this medicine will not have any noticeable effects.
  • This medicine contains maltodextrin which contains glucose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
  • If you have AIDS and your stomach becomes swollen, stop taking the tablets immediately and contact your doctor.
  • If you have liver disease. Check with your doctor before using the tablets. Some of the side-effects might be more troublesome.
  • IMODIUM® Dual Action Relief Tablets only treat the symptoms of diarrhoea. In some cases, the cause of your diarrhoea may require treatment, if symptoms persist or worsen, please contact your doctor. Taking other medicines

Talk to your doctor or pharmacist if you are taking any other medicines including:

  • Quinidine (used to treat abnormal heart rhythms or malaria)
  • Itraconazole or ketoconazole (antifungal medicines)
  • Gemfibrozil (used to treat high cholesterol)
  • Ritonavir (used to treat HIV infection and AIDS)
  • Desmopressin (used to control thirst and urine production in patients with diabetes insipidus)

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, because IMODIUM® Dual Action Relief Tablets may interact with them. If any of these bullet points apply to you now or in the past, talk to a doctor or pharmacist.

If you are pregnant or breast-feeding

  • Ask your doctor or pharmacist for advice before taking this medicine if you are pregnant, think you are pregnant or planning to become pregnant.
  • This medicine is not recommended if you are breast-feeding as small amounts of the medicine may get into your milk. Talk to your doctor about a suitable treatment.

Special warnings about this medicine

  • This medicine may make you feel dizzy, tired or sleepy. If affected do not drive or operate machinery.

Age Dose

Adults over

18 years old

Swallow two tablets initially, followed by one tablet after every loose stool (bowel movement). Children and

young adults

(12 to 18 years)

Swallow one tablet initially, followed by one tablet after every loose stool (bowel movement).

  • Do not take more than 4 tablets in a day.
  • If your symptoms persist after two days, stop taking the tablets and contact your doctor.

    If symptoms persist or get worse, or if new symptoms occur, stop use and talk to your doctor.

    • 3 –

3 How to take this medicine

Check the table below to see how much medicine to take.

  • Swallow the correct number of tablets whole with a drink of water. ■ For oral use only.
  • Do not use more than the stated dose shown in the table.

    Children under 12 years old

    Do not give the tablets to children less than 12 years old. Adults and children 12 years and over

    Unless your doctor has told you otherwise, follow these instructions:

    If anyone takes too much of this medicine

    If you have taken too many IMODIUM® Dual Action Relief Tablets immediately contact a doctor or hospital for advice. Symptoms may include: increased heart rate, irregular heartbeat, changes to your heartbeat (these symptoms can have potentially serious, life-threatening consequences), muscle stiffness, uncoordinated movements, drowsiness, difficulty urinating, weak breathing, dry mouth or the pupils of your eyes may become small, stomach pains, feel sick or vomit or be constipated.

    Children react more strongly to large amounts of IMODIUM® Dual Action Relief Tablets than adults. If a child takes too much or shows any of the above symptoms, call a doctor immediately.

    If you forget to take the medicine

    Take one tablet after the next loose stool (bowel movement). Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this product, ask your doctor or pharmacist.

4 Possible side-effects

Like all medicines, IMODIUM® Dual Action Relief Tablets can cause side-effects, although not everybody gets them.

If you experience any of the following stop using the medicine and seek immediate medical help:

turn over ▶ ■

■

■

Allergic reactions including swelling of the face, tongue or throat, difficulty swallowing, unexplained wheezing, shortness of breath which may be accompanied by skin rash or hives and skin rash which may lead to severe blistering and peeling of the skin

Loss of consciousness or decreased consciousness

Not known (frequency cannot be estimated from the available data): Upper abdominal pain, abdominal pain that radiates to back, tenderness when touching the abdomen, fever, rapid pulse, nausea, vomiting, which may be symptoms of inflammation of the pancreas (acute pancreatitis) If you experience any of the following, stop using the medicine and talk to your doctor:

  • Difficulty urinating
  • Severe abdominal pain, abdominal bulging or swelling or fever which may be due to a blocked or enlarged bowel
  • Severe constipation

Other effects which may occur include

Common side-effects (less than 1 in 10 but more than 1 in 100 people get these):

  • 4 –
  • Headache
  • Feeling sick
  • A change in the way some things taste

Uncommon side-effects (less than 1 in 100 but more than 1 in 1,000 people get these):

  • Drowsiness ■ Indigestion
  • Dizziness ■ Wind
  • Weakness ■ Dry mouth
  • Constipation ■ Rash
  • Vomiting

Rare side-effects (less than 1 in 1,000 but more than 1 in 10,000 people get these):

  • Excessive contraction of the pupil of the eye
  • Hives ■ Muscle tension
  • Itching ■ Uncoordinated movements
  • Tiredness

    Reporting of side-effects

    If you get any side-effects, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in this leaflet. You can also report side-effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

    By reporting side-effects, you can help provide more information on the safety of this medicine.

5 Storing this medicine

Keep this medicine out of the sight and reach of children. Do not use the tablets after the expiry date on the blister and box. The expiry date refers to the last day of that month. This medicinal product does not require any special storage conditions. © McNeil Products Limited 2026

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6 Further information

What’s in this medicine?

The active ingredients are: Loperamide hydrochloride (2 mg per tablet) and Simeticone (measured as 125 mg dimeticone per tablet).

The other ingredients are: Calcium hydrogen phosphate, microcrystalline cellulose, acesulfame potassium, artificial vanilla flavour (includes propylene glycol, maltodextrin, ethanol and benzyl alcohol), sodium starch glycolate (type A) and stearic acid.

What the medicine looks like

The tablets are white capsule shaped tablets marked with a line between “2” and “125” on one side and “IMO” on the other side.

Each pack contains 6, 8, 10 or 12 tablets in blister strips.

Not all pack sizes may be marketed.

Marketing Authorisation holder:

McNeil Products Limited, 1 Station Hill Square, Station Hill, Reading, RG1 1LN, UK.

Manufacturer:

JNTL Consumer Health (France) SAS, Domaine de Maigremont, Val de Reuil, 27100, France.

This leaflet was revised July 2026.

IMODIUM® is a registered trade mark.

360341E

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 15513/0342

Last revision stated in the text: July 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Imodium Dual Action Relief tablets

Prescription needed? Depends on the pack size: general sale list (GSL) – also sold outside pharmacies, pharmacy medicine (P) – sold only in pharmacies
Active substances Loperamide, Simeticone
Strength 2 mg + 125 mg
Pharmaceutical form Oral tablet
White, capsule-shaped tablets debossed with “IMO” on one side, the other side is debossed with a line between “2”and “125”.
The score line is not intended for breaking the tablets.
How is it taken Oral
Excipients Calcium hydrogen phosphate Microcrystalline cellulose, Acesulfame potassium, Artificial vanilla flavour (includes propylene glycol, maltodextrin, ethanol and benzyl alcohol), Sodium starch glycolate (type A), Stearic acid.
Pack sizes 6 tablet, 12 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Antipropulsive antidiarrheals
  1. A Alimentary tract and metabolism drugs
    1. A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
      1. A07D Antipropulsives
        1. A07DA Antipropulsives
          1. A07DA53 loperamide, combinations
Marketing authorisation PL 15513/0342 (first authorised 1 September 2007)
Marketing authorisation holder McNeil Products Limited
Codes GTIN 3574661609416, 3574661609423 · BNF 01040200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.